# Study of Descartes-30 in Acute Respiratory Distress Syndrome

> **NCT04524962** · PHASE1 · TERMINATED · sponsor: **Cartesian Therapeutics** · enrollment: 12 (actual)

## Conditions studied

- Acute Respiratory Distress Syndrome
- Covid19

## Interventions

- **BIOLOGICAL:** Descartes 30

## Key facts

- **NCT ID:** NCT04524962
- **Lead sponsor:** Cartesian Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-02-23
- **Primary completion:** 2022-09-09
- **Final completion:** 2023-09-09
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Phase 1 enrollment completed. Further clinical development terminated
- **Last updated:** 2024-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04524962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04524962, "Study of Descartes-30 in Acute Respiratory Distress Syndrome". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04524962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*